EVMN
Evommune, Inc.
NYSE: EVMN · HEALTHCARE · BIOTECHNOLOGY
$23.80
-0.21% today
Updated 2026-04-30
Market cap
$914.15M
P/E ratio
—
P/S ratio
70.32x
EPS (TTM)
$-11.22
Dividend yield
—
52W range
$14 – $33
Volume
0.3M
Evommune, Inc. (EVMN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |